FDA committee recommends approval of Braeburn Pharmaceuticals' CAM-2038 for opioid use disorder Nov. 2, 2017 No Comments
NIDA grant supports Camino Pharma's development of compounds for substance use disorders Sep. 29, 2017 No Comments
Aeolus Pharmaceuticals' AEOL-10150 safe and well-tolerated in phase I study Sep. 20, 2017 No Comments
Emergent Biosolutions awarded funding to develop antidote spray for cyanide poisoning Sep. 20, 2017 No Comments
RSS